Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Mar 30:21:200263.
doi: 10.1016/j.ijcrp.2024.200263. eCollection 2024 Jun.

Use of the biomarker score in determining the risk of heart failure in diabetics in Goma, North Kivu in the Democractic Republic of the Congo

Ferdinand Ng'ekieb Mukoso  1   2   3 , Aliocha Natuhoyila Nkodila  4 , Hippolyte Nani Tuma Situakibanza  5 , Stannislas Okitotsho Wembonyama  6   7 , Zacharie Kibendelwa Tsongo  8
Affiliations
Editorial

Use of the biomarker score in determining the risk of heart failure in diabetics in Goma, North Kivu in the Democractic Republic of the Congo

Ferdinand Ng'ekieb Mukoso et al. Int J Cardiol Cardiovasc Risk Prev. .

Abstract

Background: The use of biomarkers, such as N-terminal pro-brain natriuretic peptide (NTpBNP), high-sensitivity C-reactive protein (hs-CRP) and high-sensitivity troponin (hs-TnI) is an alternative approach to detect the risk of heart failure (HF), but data on this approach are fragmentary in sub-Saharan Africa. The objective of this study is to determine the correlation between the risk of heart failure and the score of biomarkers in the population of asymptomatic diabetics in the city of GOMA.

Methods: Asymptomatic diabetics in the city of Goma were cross-sectionally recruited at the Center of the Association of Diabetics in Congo (ADIC) in Goma, DRC during the period from February 5 to 19, 2023. The risk of insufficiency heart rate at 5 years was determined using pulse pressure. The biomarker score was calculated using NTproBNP, hs-CRP, hs-troponin and left ventricular hypertrophy (LVH). The association between the risk of heart failure and the biomarker score was evaluated using the logistic regression test at the threshold of p < 0.05.

Results: Of a total of 408 diabetic patients examined, 29.9% had presented a risk of heart failure. The risk of heart failure was higher in patients with a high biomarker score (57.7%), in patients with type 1 diabetes (60%) and in patients with type 2 diabetes (57.1%). Independent risk of biomarker score on occurrence of heart failure. The risk of heart failure was multiplied by 2 if the biomarker score was intermediate (OR: 2.19, 95% CI: 1.11-4.34) and by 5 if the biomarker score was high (OR: 4.73, 95% CI: 1.84-6.20).

Conclusion: The biomarker score is associated with the risk of heart failure in our study via the increase in the score elements as reported in European studies.

Keywords: Asymptomatic diabetic; Risk of heart failure; Using biomarker score.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest regarding the publication of this paper.

Figures

Fig. 1
Fig. 1
Participant flowchart.
Fig. 2
Fig. 2
Risk of heart failure according to biomarker score.
See this image and copyright information in PMC

References

    1. Mwana-waben A.C., Lwamushi S.M., Eboma C.M., Pacifique M.B., Lyab B.C., Karemere H., et al. Choix thérapeutiques des hypertendus et diabétiques en milieu rural : une étude mixte dans deux zones de santé de l'Est de la République Démocratique du Congo. African Journal of Primary Health Care & Family Medicine. 2022:1–9. - PMC - PubMed
    1. Cho N., Shaw J., Karuranga S., Huang Y., Fernandes J.D.R., Ohlrogge A., Malanda B. IDF Diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res. Clin. Pract. 2018;138:271–281. - PubMed
    1. Lichtenauer M., Jirak P., Paar V., Sipos B., Kopp K., Berezin A.E. Heart failure and diabetes mellitus: biomarkers in risk stratification and prognostication. Appl. Sci. 2021;11(10):4397. doi: 10.3390/app11104397. - DOI
    1. Glovaci D., Fan W., Wong N.D. Epidemiology of diabetes mellitus and cardiovascular disease. Curr. Cardiol. Rep. 2019;21:21. - PubMed
    1. Ziaeian B., Fonarow B.Z.G.C. Epidemiology and aetiology of heart failure. Nat. Rev. Cardiol. 2016;13:368–378. - PMC - PubMed

Publication types

LinkOut - more resources